Telehealth Study Reveals Fast, Oversight-Lacking GLP-1 Prescriptions
A secret shopper study has unveiled the prescribing practices of nearly 50 telehealth sites offering…
Newswire
ALS Drug Extends Survival in Mice, Targets TDP-43 Low-Complexity Domain
In a new study published in Nature Aging, researchers from the University of Arizona present…
Novartis to Acquire ADC Developer in a Deal Worth Up to $1.5B
Novartis has announced its intention to acquire the ADC developer Myricx for a deal valued…
Novartis Acquires Myricx Bio for $1.1 Billion to Enhance Cancer Drug Development
Novartis has announced its acquisition of Myricx Bio for $1.1 billion upfront, a strategic move…
Cancer, immune drugmakers dominate VC funding so far in 2026
Drug developers focusing on either cancer or immunology have accounted for over 40% of the…
Greater Boston’s Job Losses Prompt Rise of Unlikely Biotech Hubs
As Greater Boston’s biotech industry sheds jobs, three unlikely regions—Las Vegas, Oklahoma, and Pennsylvania—are emerging…
Novartis Invests $1.1 Billion in Myricx Bio to Enhance ADC Pipeline
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx…
The race for an Ebola therapy begins
The global pharmaceutical industry is witnessing an intensified race to develop effective therapies for Ebola,…
MHRA Innovation Office Provides Crucial Regulatory Guidance for Innovative Medicine Developers
The MHRA’s Innovation Office has been established to provide essential regulatory guidance to developers of…
FDA Expands Vertex’s Casgevy Label to Include Patients as Young as 2
Vertex Pharmaceuticals has received FDA approval for a label expansion of its gene therapy Casgevy,…